Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Researchers, policy experts to examine issue of declining enrollment in clinical trials

Researchers, policy experts to examine issue of declining enrollment in clinical trials

New guide indicates when and how genetic testing is useful for inherited cardiac conditions

New guide indicates when and how genetic testing is useful for inherited cardiac conditions

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

St. Jude Medical introduces HD VantageView System for enhancing EP lab workflow

St. Jude Medical introduces HD VantageView System for enhancing EP lab workflow

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

CICC White Paper identifies several care gaps of atrial fibrillation patients in Ontario

CICC White Paper identifies several care gaps of atrial fibrillation patients in Ontario

ARCA plans to expand development program for Gencaro in atrial fibrillation

ARCA plans to expand development program for Gencaro in atrial fibrillation

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

Novel gene associated with heart development and aging process

Novel gene associated with heart development and aging process

MHI team uses cryoablation to successfully treat atrial fibrillation

MHI team uses cryoablation to successfully treat atrial fibrillation

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

MHA's annual awards recognize outstanding health care leaders, innovative programs

MHA's annual awards recognize outstanding health care leaders, innovative programs

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

NYU Langone researchers present recent findings at The Heart Rhythm Society 32nd annual sessions

Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report

Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report

ESC Heart Failure meeting offers strong scientific programme

ESC Heart Failure meeting offers strong scientific programme

New cardiac resynchronization therapy data in atrial fibrillation presented at Heart Rhythm 2011

New cardiac resynchronization therapy data in atrial fibrillation presented at Heart Rhythm 2011

New cardiac genetic testing guidelines for health care professionals

New cardiac genetic testing guidelines for health care professionals

Biosense Webster enters new agreement with Stereotaxis to deploy Odyssey products

Biosense Webster enters new agreement with Stereotaxis to deploy Odyssey products

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.